Immunotherapy
5.25
credits/contact hours

Learn From the Experts About Collaborative Practice in the Management of Cancer Patients

Develop your expertise in side effect management, recognition, and timing for immunotherapy-related adverse events for several disease states, including melanoma, non–small cell lung cancer, and urothelial carcinoma. Join the presenters as they show how to put the information into practice through case-based interactive discussions.

 

Pittsburgh, PA • October 21

Herberman Conference Center 5150 Centre Ave. 2nd Floor • Pittsburgh, PA 15232Register Now

LEARNING OBJECTIVES

Upon completion of this activity, participants will be able to:

  • Differentiate between early and latent adverse effects associated with immunotherapeutic agents.
  • Recognize the differences between the immunotherapeutic agents and of chemotherapeutic agents: mechanisms of action, adverse effects, and toxicity management.
  • Describe the concept of “pseudo-progression” associated with immunotherapeutic agents and identify ways to differentiate this occurrence from real disease progression.

REGISTRATION FEE

  Member Non-Member
Registration $25.00 $50.00

AGENDA

7:30 am Registration
8:00 am Breakfast
9:00 am Welcome and Introductions
9:15 am Overview of The Immune System – 2.00 Contact Hours        
  • T-Cells, Natural Killer Cells
  • Immuno-Oncology Mechanisms of Action            
    • CTLA4
    • PD1
    • PDL1
    • T-VEC
11:15 am Break
11:30 am Case Studies in Melanoma: Anticipation and Management of Side Effects – 0.50 Contact Hours
12:00 pm LUNCH BREAK
1:15 pm Case Studies in NSCLC: Anticipation and Management of Side Effects – 0.50 Contact Hours
1:45 pm Case Studies in Urothelial Carcinoma: Anticipation and Management of Side Effects – 0.50 Contact Hours
2:15 pm Break
2:30 pm Case Studies in Renal Cell Carcinoma: Anticipation and Management of Side Effects – 0.50 Contact Hours
3:00 pm Case Studies in Head and Neck Cancer: Anticipation and Management of Side Effects – 0.50 Contact Hours
3:30 pm Case Studies in classical Hodgkin Lymphoma: Anticipation and Management of Side Effects – 0.50 Contact Hours
4:00 pm Reflections on the day – 0.25 Contact Hours
4:15 pm Program adjourns

*Program times are subject to change.

Pittsburgh, PA • October 21

Herberman Conference Center 5150 Centre Ave. 2nd Floor • Pittsburgh, PA 15232Register Now

ACCREDITATION


Physicians: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Annenberg Center for Health Sciences at Eisenhower, the Advanced Practitioner Society for Hematology and Oncology, and the Journal of the Advanced Practitioner in Oncology. The Annenberg Center is accredited by the ACCME to provide continuing medical education for physicians.

The Annenberg Center for Health Sciences at Eisenhower designates this live activity for a maximum of 5.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses: The Annenberg Center for Health Sciences at Eisenhower is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

A maximum of 5.25 contact hours may be earned for successful completion of this activity.

Pharmacists: The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program has been assigned ACPE Universal Program 0797-9999-17-034-L01-P.

This program is designated for up to 5.25 contact hours (0.525 CEUs) of continuing pharmacy education credit.

PAs: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 CreditTM from organizations accredited by ACCME or a recognized state medical society.

PAs may receive a maximum of 5.25 Category 1 credits for completing this activity.

Support provided by educational grants from Merck Sharp & Dohme Corp.

This CE/CME/CEU accredited conference is jointly provided by